#USA #rheumatoid arthritis #Ventura #St. John's Regional Medical Center #Modulation Device

Leading Medical Innovation: A New Hope for Rheumatoid Arthritis Patients at St. John's Regional Medical Center

In recent news, St. John's Regional Medical Center (SJRMC), located in Ventura, California, has taken a pioneering step in the medical field by introducing an innovative treatment for rheumatoid arthritis (RA). With nearly 1.5 million Americans affected by this chronic and progressive inflammatory condition, the launch of this new FDA-approved device represents a significant breakthrough in the management of a disease that can severely hinder patients' quality of life.

Overview of the New Treatment

The treatment, termed 'neuromodulation', is the first of its kind in California. This approach works by providing targeted stimulation to the left vagus nerve, thereby activating neuronal pathways that help in regulating the immune system's activity. This novel approach is particularly beneficial for adults struggling with moderate to severe RA who haven’t effectively responded to traditional therapies, such as biological and synthetic disease-modifying antirheumatic drugs (DMARDs).

Dr. Akinwunmi Oni-Orisan and his surgical team successfully performed the first procedure in this initiative, marking a monumental moment in California's healthcare landscape. Dr. Oni-Orisan emphasized, "This neuromodulation approach reflects St. John's commitment to being at the forefront of advanced surgical technologies that better serve our communities."

A Game-Changer for Patients

What sets this device apart is its specific focus on chronic autoimmune conditions, offering a new avenue for treatment that is designed to enhance patients' outcomes. Dr. Gita Fatemi, a rheumatologist at St. John’s, expressed her enthusiasm: “I am delighted to offer our community a pioneering technology with unprecedented safety. This method could lead to significantly improved results for those battling one of the most life-altering autoimmune disorders.”

Partnership With SetPoint Medical

The introduction of this advanced technology comes through a close partnership with SetPoint Medical, the developers of the neuromodulation device. Murthy Simhambhatla, CEO of SetPoint Medical, stated, “Partnering with St. John's to bring neuromodulation therapy to patients across California is a crucial milestone in enhancing access to innovative therapeutic solutions that target the neuronal pathways responsible for inflammation. Working with forward-thinking healthcare systems like St. John's accelerates our mission to transform rheumatoid arthritis treatment and provides meaningful innovation for both patients and healthcare providers.”

The Future of RA Treatment

As the medical community gears up to embrace this fresh approach to handling RA, patients who are affected by moderate to severe forms of the condition are encouraged to consult their rheumatologists to explore advanced treatment options available at SJRMC. The hospital has a long-standing reputation for its commitment to high-quality patient care, having providing intensive care for over a century.

For more information about this groundbreaking treatment, visit dignityhealth.org/stjohnsregional.

About St. John's Regional Medical Center

St. John's Regional Medical Center and St. John's Hospital Camarillo stand as the largest non-profit provider of critical care in Ventura County. With a legacy dating back 110 years, these hospitals are nationally recognized for the quality of their care, safety, and services. Both facilities are backed by a philanthropic foundation aimed at enhancing community access to healthcare and developing new programs and services. For further insights into their offerings, please visit their respective websites.

This announcement embodies a forward-thinking approach to healthcare, showcasing St. John’s dedication to bringing advanced medical solutions to the forefront, thereby making a significant impact on the lives of numerous individuals affected by rheumatoid arthritis.